Home › NDC Lookup › Ingredients › Glycerin › 83033-0100-01
ANTIBACTERIAL COOLING BREEZE GLYCERIN 1 g/g Soap, 500 g — NDC 83033-0100-01 package photo

ANTIBACTERIAL COOLING BREEZE GLYCERIN 1 g/g Soap, 500 g

by Quimicas Handal de Centroamerica SA de CV · 500 g in 1 BOTTLE, WITH APPLICATOR (83033-0100-1)
NDC 83033-0100-01
🏷️ FDA NDC (as labeled) 83033-0100-1 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Glycerin (different manufacturers) — 4 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 27, 2026 — Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision. (Oasis Medical, Inc.) · FDA recall D-0525-2026
Class II · Apr 20, 2026 — Lack of Assurance of Sterility (SCOPE HEALTH) · FDA recall D-0499-2026
Class II · Mar 25, 2026 — Lack of Assurance of Sterility (Preferred Pharmaceuticals, Inc.) · FDA recall D-0443-2026
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0411-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 83033-0100-1
Product NDC 83033-0100
11-digit billing NDC 83033010001
UNII PDC6A3C0OX
Application # M016
SPL Set ID 09f73bec-516d-90f0-e063-6394a90aecab
Established class (EPC) Non-Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Allergens; Glycerol
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-11-11
Route TRANSDERMAL
Dosage form SOAP
Substance GLYCERIN
Why two NDCs? The FDA registers this code as 83033-0100-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 83033-0100-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerQuimicas Handal de Centroamerica SA de CV
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code83033
First marketedNov 2022
Product typeHuman Otc Drug
Portfolio24 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an over-the-counter soap product containing glycerin as its active ingredient. Glycerin is commonly used in cleansing products for its skin-conditioning properties, as it functions to help retain moisture in the skin. The product is marketed as an antibacterial soap with a cooling breeze fragrance. As an OTC monograph drug, this soap is manufactured under FDA's established guidelines for over-the-counter soap products.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • 1 g / 1 g UNII 92005F972D
    A foaming and thickening agent derived from coconut oil. It's used in liquid medicines to improve texture, help distribute active ingredients evenly, and create a pleasant consistency for easier swallowing or application.
  • 1 g / 1 g UNII MP1J8420LU
    A salt derived from edetic acid that binds to trace metals in medicines. It serves as a chelating agent and preservative to prevent metal-catalyzed breakdown of the drug and extend shelf life.
  • 1 g / 1 g UNII DEL7T5QRPN
    A synthetic preservative that kills bacteria and fungi. It's added to medications to prevent microbial growth and extend shelf life, especially in liquid or topical formulations.
  • 1 g / 1 g UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • 1 g / 1 g UNII BPV390UAP0
    Sodium laureth sulfate is a mild detergent and surfactant derived from coconut oil or petroleum. It helps mix oil and water in formulations and is often used as a cleaning or foaming agent in topical products like shampoos and cleansers.
  • 1 g / 1 g UNII 5PGH842FAU
    A detergent and surfactant derived from coconut oil. It helps break down oils and water in formulations to improve mixing, acts as a cleanser in some products, and aids in distributing active ingredients evenly throughout the medicine.
  • 1 g / 1 g UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesINACTIVE INGREDIENTS: Aqua, Sodium Laureth Sulfate, Sodium chloride, Sodium Lauroyl Sarcosinate, Cocamide DEA, Methylchloroisothiazolinone, Paum, Citric Acid, Tetrasodium EDTA, CI 60725, CI 17200.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Antibacterial Delightful Sweetness 1 g/g 83033-0080-01 Quimicas 500 g — — FDA listed —
Antibacterial Dreamy Florals 1 g/g 83033-0010-01 Quimicas 300 g — — FDA listed —
Antibacterial Delightful Sweetness 1 g/g 83033-0030-01 Quimicas 300 g — — FDA listed —
Antibacterial Cooling Breeze 1 g/g 83033-0050-01 Quimicas 300 g — — FDA listed —
Antibacterial Bold Citrus 1 g/g 83033-0070-01 Quimicas 500 g — — FDA listed —
Antibacterial Cooling Breeze 1 g/gthis 83033-0100-01 Quimicas 500 g — — FDA listed —
Antibacterial Dreamy Florals 1 g/g 83033-0060-01 Quimicas 500 g — — FDA listed —
Antibacterial Bold Citrus 1 g/g 83033-0020-01 Quimicas 300 g — — FDA listed —
Antibacterial Fruity Zest 1 g/g 83033-0090-01 Quimicas 500 g — — FDA listed —
Antibacterial Fruity Zest 1 g/g 83033-0040-01 Quimicas 300 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2022
On the market since
Nov 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for GLYCERIN — the ingredient across all brands.

Top reported reactions

Oral Herpes2,427
Condition Aggravated2,018
Eye Irritation1,068
Eye Pain1,013
Incorrect Drug Administration Duration806
Pain758
Herpes Simplex709

Age at onset

Neonate3
Infant11
Child22
Adolescent14
Adult831
Elderly1,496

Reporter sex

23,937 reports
Male · 27%
Female · 73%
Unknown · 0%

Serious outcomes

Hospitalization2,612
Death681
Life-threatening414
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 1,507 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
83033-0100-01 You're viewing this 500 g in 1 BOTTLE, WITH APPLICATOR (83033-0100-1) 2022-11-11 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 83033-0100-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 83033-0100-01, written without dashes as 83033010001. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 83033-0100-01, the first segment (83033) is the labeler code FDA assigned to Quimicas Handal de Centroamerica SA de CV; the middle segment (0100) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Quimicas Handal de Centroamerica SA de CV. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Quimicas Handal de Centroamerica SA de CV is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 29 words ▾

Pump Caviani hand soap into hands and lather vigorously, from your wrist to your fingertips. Rinse thoroughly to remove soap. Complete these steps in 20 seconds, repeat if necessary.

⏱️ Dosage and Administration 29 words ▾

Pump Caviani hand soap into hands and lather vigorously, from your wrist to your fingertips. Rinse thoroughly to remove soap. Complete these steps in 20 seconds, repeat if necessary.

⚠️ Warnings 50 words ▾

Avoid contact with eyes. Hold eye open and rinse slowly and gently with water. Minors should be supervised while using this product. KEEP OUT OF REACH OF CHILDREN. IN CASE OF INGESTION: Rinse mouth with water, seek amedical assistance. IN CASE OF INTOXICATION: CONSULT YOUR DOCTOR AND PROVIDE THIS LABEL.

🧪 Active Ingredient 1 words ▾

GLYCERIN

🧪 Inactive Ingredients 23 words ▾

INACTIVE INGREDIENTS: Aqua, Sodium Laureth Sulfate, Sodium chloride, Sodium Lauroyl Sarcosinate, Cocamide DEA, Methylchloroisothiazolinone, Paum, Citric Acid, Tetrasodium EDTA, CI 60725, CI 17200.

🎯 Purpose 8 words ▾

enhanced protection against germs and delivers lasting nourishment.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 83033-0090-01 · Quimicas 83033-1594-01 · Quimicas →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.